Ultragenyx Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results

Published: Mar 24, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NOVATO, Calif., March 24, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial results and business highlights for the fourth quarter and year ended December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news